These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 9029747
1. Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. Takayanagui OM, Lanchote VL, Marques MP, Bonato PS. Ther Drug Monit; 1997 Feb; 19(1):51-5. PubMed ID: 9029747 [Abstract] [Full Text] [Related]
2. Pharmacokinetic optimisation of the treatment of neurocysticercosis. Sotelo J, Jung H. Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011 [Abstract] [Full Text] [Related]
3. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Lanchote VL, Garcia FS, Dreossi SA, Takayanagui OM. Ther Drug Monit; 2002 Jun; 24(3):338-45. PubMed ID: 12021623 [Abstract] [Full Text] [Related]
4. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. Jung H, Hurtado M, Sanchez M, Medina MT, Sotelo J. J Clin Pharmacol; 1992 Jan; 32(1):28-31. PubMed ID: 1740534 [Abstract] [Full Text] [Related]
5. Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase. Paias FO, Lanchote VL, Takayanagui OM, Bonato PS. Chirality; 1997 Jan; 9(8):722-6. PubMed ID: 9435097 [Abstract] [Full Text] [Related]
6. Dexamethasone increases plasma levels of albendazole. Jung H, Hurtado M, Medina MT, Sanchez M, Sotelo J. J Neurol; 1990 Aug; 237(5):279-80. PubMed ID: 2230841 [Abstract] [Full Text] [Related]
7. Effect of dexamethasone on albendazole cysticidal activity in experimental cysticercosis by Taenia crassiceps in BALB/c mice: In vitro and in vivo evaluation. Palomares-Alonso F, Toledo A, Palencia Hernández G, Jung-Cook H, Fleury A. Exp Parasitol; 2020 Jan; 208():107801. PubMed ID: 31730781 [Abstract] [Full Text] [Related]
8. Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis. Takayanagui OM, Bonato PS, Dreossi SA, Lanchote VL. Br J Clin Pharmacol; 2002 Aug; 54(2):125-30. PubMed ID: 12207631 [Abstract] [Full Text] [Related]
14. Pharmacokinetic comparison of two albendazole dosage regimens in patients with neurocysticercosis. Sánchez M, Suástegui R, González-Esquivel D, Sotelo J, Jung H. Clin Neuropharmacol; 1993 Feb; 16(1):77-82. PubMed ID: 8422660 [Abstract] [Full Text] [Related]
15. Treatment of brain cysticercosis. Sotelo J. Surg Neurol; 1997 Aug; 48(2):110-2. PubMed ID: 9242234 [No Abstract] [Full Text] [Related]
16. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. Jung H, Hurtado M, Sanchez M, Medina MT, Sotelo J. Clin Neuropharmacol; 1990 Dec; 13(6):559-64. PubMed ID: 2276121 [Abstract] [Full Text] [Related]
17. Population pharmacokinetics of albendazole in patients with neurocysticercosis. Castro N, Márquez-Caraveo C, Brundage RC, González-Esquivel D, Suárez AM, Góngora F, Jara A, Urizar J, Lanao JM, Jung H. Int J Clin Pharmacol Ther; 2009 Nov; 47(11):679-85. PubMed ID: 19840532 [Abstract] [Full Text] [Related]